China’s first AI-powered cancer vaccine production line set to launch in Beijing
China has initiated construction of its first AI-assisted personalized cancer vaccine production line in Beijing. The new facility, expected to be completed by October, aims to boost drug research and manufacturing and benefit millions of cancer patients in the country.
China AI cancer vaccine medical technology Beijing
Linked Entities
Contributing Articles
New high-speed rail bridges central, western China for coordinated development
Borneo Post —
Rosatom supplied nuclear island control systems for Xudapu NPP in China
TASS —
Wagenborg and Carisbrooke line up ice-class newbuilds in China
Splash247 Maritime —
China opens first zero-carbon sea-river electric container route
Splash247 Maritime —
Dans le Guizhou, la frénésie de construction de ponts et d’autoroutes se heurte au mur de la dette
Le Monde —
PDD embraces China’s ‘city of the future’ after bruising regulatory clash and record fine
South China Morning Post —
World's 'largest TLP floating wind turbine' to power Chinese oil field
Windpower Monthly —
Bilateral talks advance key infrastructure projects in Beijing
Khmer Times —
China’s $295 Billion Ambitions for AI Will Drive up Domestic High-Tech Stocks
The Diplomat —
Hainan’s Sanya to host Formula E World Championship round in April 2027
TASS —